NL
ARKG icon

NWAM LLC’s ARK Genomic Revolution ETF ARKG Stock Holding History

NWAM LLC’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$539K Buy
20,410
+5,244
+35% +$154K 0.03% 386
2025
Q4 		$439K Buy
+15,166
New +$455K 0.02% 418
2022
Q2 		– Sell
-4,712
Closed -$216K – 514
2022
Q1 		$216K Buy
+4,712
New +$225K 0.02% 497
2021
Q3 		– Sell
-2,906
Closed -$269K – 496
2021
Q2 		$269K Buy
2,906
+421
+17% +$35.8K 0.03% 396
2021
Q1 		$220K Buy
+2,485
New +$246K 0.02% 441

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

NWAM LLC's ARKG Position: Q1 2026 in Review

NWAM LLC increased its ARK Genomic Revolution ETF (ARKG) stake by 35% in Q1 2026, buying an estimated $154K and bringing the position to 20,410 shares worth $539K. The position accounts for 0.03% of the portfolio, ranked #386.

NWAM LLC first reported a position in ARKG in Q1 2021 and has held it in 5 quarters since. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

  • NWAM LLC held 20,410 shares of ARK Genomic Revolution ETF worth $539K as of Q1 2026.
  • NWAM LLC bought 5,244 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $154K.
  • ARK Genomic Revolution ETF made up 0.03% of NWAM LLC's portfolio in Q1 2026, its #386 holding.
  • NWAM LLC first reported a position in ARK Genomic Revolution ETF in Q1 2021 and has held it in 5 quarters since.
  • 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on NWAM LLC's 13F filing for Q1 2026, filed 4 May 2026.